Abstract
The innate immune system and its complex interplay with the adaptive immune system are increasingly being recognized as important factors in the pathogenesis of chronic rhinosinusitis (CRS). Adaptive immune components, including resident and inflammatory cells, and their associated mediators, have been the subject of most research in CRS. For this reason, theories of CRS pathogenesis have involved the concept that inflammation, rather than infection, is the dominant etiologic factor in CRS. Therefore, glucocorticoids are increasingly used to treat CRS. This review will outline our current knowledge of action mode of glucocorticoids in CRS.
| Original language | English |
|---|---|
| Pages (from-to) | 534-537 |
| Number of pages | 4 |
| Journal | Allergy, Asthma and Immunology Research |
| Volume | 7 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2015 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© The Korean Academy of Asthma, Allergy and Clinical Immunology.
Keywords
- Chronic rhinosinusitis
- Cytokines
- Glucocorticoid receptor
- Glucocorticoids
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Pulmonary and Respiratory Medicine